Suppr超能文献

新型冠状病毒(SARS-CoV-2)膜蛋白的结构类似于糖转运蛋白SemiSWEET。

The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter SemiSWEET.

作者信息

Thomas Sunil

机构信息

Lankenau Institute for Medical Research, Wynnewood, PA-19096, USA.

出版信息

Pathog Immun. 2020 Oct 19;5(1):342-363. doi: 10.20411/pai.v5i1.377. eCollection 2020.

Abstract

BACKGROUND

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the disease COVID-19 that has decimated the health and economy of our planet. The virus causes the disease not only in people but also in companion and wild animals. People with diabetes are at risk of the disease. As yet we do not know why the virus has been highly successful in causing the pandemic within 3 months of its first report. The structural proteins of SARS include membrane glycoprotein (M), envelope protein (E), nucleocapsid protein (N), and the spike protein (S).

METHODS

The structure and function of the most abundant structural protein of SARS-CoV-2, the membrane (M) glycoprotein, is not fully understood. Using analyses we determined the structure and potential function of the M protein.

RESULTS

The M protein of SARS-CoV-2 is 98.6% similar to the M protein of bat SARS-CoV, maintains 98.2% homology with pangolin SARS-CoV, and has 90% homology with the M protein of SARS-CoV; whereas, the similarity is only 38% with the M protein of MERS-CoV. analyses showed that the M protein of SARS-CoV-2 has a triple helix bundle, forms a single 3-trans-membrane domain, and is homologous to the prokaryotic sugar transport protein SemiSWEET. SemiSWEETs are related to the PQ-loop family whose members function as cargo receptors in vesicle transport, mediate movement of basic amino acids across lysosomal membranes, and are also involved in phospholipase flippase function.

CONCLUSIONS

The advantage and role of the M protein having a sugar transporter-like structure is not clearly understood. The M protein of SARS-CoV-2 interacts with S, E, and N protein. The S protein of the virus is glycosylated. It could be hypothesized that the sugar transporter-like structure of the M protein influences glycosylation of the S protein. Endocytosis is critical for the internalization and maturation of RNA viruses, including SARS-CoV-2. Sucrose is involved in endosome and lysosome maturation and may also induce autophagy, pathways that help in the entry of the virus. Overall, it could be hypothesized that the SemiSWEET sugar transporter-like structure of the M protein may be involved in multiple functions that may aid in the rapid proliferation, replication, and immune evasion of the SARS-CoV-2 virus. Biological experiments would validate the presence and function of the SemiSWEET sugar transporter.

摘要

背景

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引发了COVID-19疾病,该疾病已对全球健康和经济造成重创。这种病毒不仅会感染人类,还会感染伴侣动物和野生动物。糖尿病患者易感染该疾病。目前我们尚不清楚为何这种病毒在首次报告后的3个月内就成功引发了全球大流行。SARS的结构蛋白包括膜糖蛋白(M)、包膜蛋白(E)、核衣壳蛋白(N)和刺突蛋白(S)。

方法

SARS-CoV-2最丰富的结构蛋白——膜(M)糖蛋白的结构和功能尚未完全明确。我们通过分析确定了M蛋白的结构和潜在功能。

结果

SARS-CoV-2的M蛋白与蝙蝠SARS-CoV的M蛋白相似度为98.6%,与穿山甲SARS-CoV保持98.2%的同源性,与SARS-CoV的M蛋白同源性为90%;而与中东呼吸综合征冠状病毒(MERS-CoV)的M蛋白相似度仅为38%。分析表明,SARS-CoV-2的M蛋白具有三螺旋束,形成单一的3跨膜结构域,与原核糖转运蛋白SemiSWEET同源。SemiSWEETs与PQ环家族相关,该家族成员在囊泡运输中充当货物受体,介导碱性氨基酸跨溶酶体膜的转运,还参与磷脂酶翻转酶功能。

结论

M蛋白具有类似糖转运蛋白结构的优势和作用尚不清楚。SARS-CoV-2的M蛋白与S、E和N蛋白相互作用。该病毒的S蛋白是糖基化的。可以推测,M蛋白类似糖转运蛋白的结构会影响S蛋白的糖基化。内吞作用对于包括SARS-CoV-2在内的RNA病毒的内化和成熟至关重要。蔗糖参与内体和溶酶体成熟,也可能诱导自噬,这些途径有助于病毒进入。总体而言,可以推测M蛋白的SemiSWEET类似糖转运蛋白结构可能参与多种功能,这些功能可能有助于SARS-CoV-2病毒的快速增殖、复制和免疫逃逸。生物学实验将验证SemiSWEET类似糖转运蛋白的存在和功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fb8/7608487/5ce27d1ad6e4/pai-5-342-g001.jpg

相似文献

1
The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter SemiSWEET.
Pathog Immun. 2020 Oct 19;5(1):342-363. doi: 10.20411/pai.v5i1.377. eCollection 2020.
2
Properties of Coronavirus and SARS-CoV-2.
Malays J Pathol. 2020 Apr;42(1):3-11.
4
Current Strategies of Antiviral Drug Discovery for COVID-19.
Front Mol Biosci. 2021 May 13;8:671263. doi: 10.3389/fmolb.2021.671263. eCollection 2021.
5
SARS-CoV-2 Harnesses Host Translational Shutoff and Autophagy To Optimize Virus Yields: the Role of the Envelope (E) Protein.
Microbiol Spectr. 2023 Feb 14;11(1):e0370722. doi: 10.1128/spectrum.03707-22. Epub 2023 Jan 9.
6
Structural basis for the facilitative diffusion mechanism by SemiSWEET transporter.
Nat Commun. 2015 Jan 19;6:6112. doi: 10.1038/ncomms7112.
7
Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions.
Saudi J Biol Sci. 2022 Apr;29(4):1981-1997. doi: 10.1016/j.sjbs.2021.12.020. Epub 2021 Dec 13.
8
Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2.
Arch Med Res. 2020 Aug;51(6):482-491. doi: 10.1016/j.arcmed.2020.05.012. Epub 2020 May 25.
10
Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins.
Nature. 2020 Jul;583(7815):286-289. doi: 10.1038/s41586-020-2313-x. Epub 2020 May 7.

引用本文的文献

1
Transcription Kinetics in the Coronavirus Life Cycle.
Wiley Interdiscip Rev RNA. 2025 Jan-Feb;16(1):e70000. doi: 10.1002/wrna.70000.
3
NK Cell and Monocyte Dysfunction in Multisystem Inflammatory Syndrome in Children.
J Immunol. 2024 Nov 15;213(10):1452-1466. doi: 10.4049/jimmunol.2400395.
4
In Silico Design of a Trans-Amplifying RNA-Based Vaccine against SARS-CoV-2 Structural Proteins.
Adv Virol. 2024 Sep 30;2024:3418062. doi: 10.1155/2024/3418062. eCollection 2024.
5
Development and characterization of monoclonal antibodies recognizing nucleocapsid protein of multiple SARS-CoV-2 variants.
Heliyon. 2024 Jul 27;10(15):e35325. doi: 10.1016/j.heliyon.2024.e35325. eCollection 2024 Aug 15.
7
SARS-CoV-2 amyloid, is COVID-19-exacerbated dementia an amyloid disorder in the making?
Front Dement. 2023 Jul 6;2:1233340. doi: 10.3389/frdem.2023.1233340. eCollection 2023.
8
COVID-19 Variants and Vaccine Development.
Viruses. 2024 May 10;16(5):757. doi: 10.3390/v16050757.
10
Within-host evolution of SARS-CoV-2: how often are mutations transmitted from symptomatic infections?
Virus Evol. 2024 Feb 21;10(1):veae006. doi: 10.1093/ve/veae006. eCollection 2024.

本文引用的文献

1
Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19.
Diabetes Metab J. 2021 Mar;45(2):251-259. doi: 10.4093/dmj.2020.0206. Epub 2021 Mar 5.
2
An evidence review of face masks against COVID-19.
Proc Natl Acad Sci U S A. 2021 Jan 26;118(4). doi: 10.1073/pnas.2014564118.
3
A Carbohydrate-Binding Protein from the Edible Lablab Beans Effectively Blocks the Infections of Influenza Viruses and SARS-CoV-2.
Cell Rep. 2020 Aug 11;32(6):108016. doi: 10.1016/j.celrep.2020.108016. Epub 2020 Jul 24.
4
5
Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics?
Biomed Res Int. 2020 May 30;2020:4389089. doi: 10.1155/2020/4389089. eCollection 2020.
6
Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy.
Environ Res. 2020 Sep;188:109819. doi: 10.1016/j.envres.2020.109819. Epub 2020 Jun 13.
8
Vulnerabilities in coronavirus glycan shields despite extensive glycosylation.
Nat Commun. 2020 May 27;11(1):2688. doi: 10.1038/s41467-020-16567-0.
9
A systematic review of asymptomatic infections with COVID-19.
J Microbiol Immunol Infect. 2021 Feb;54(1):12-16. doi: 10.1016/j.jmii.2020.05.001. Epub 2020 May 15.
10
COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?
J Diabetes. 2020 Sep;12(9):649-658. doi: 10.1111/1753-0407.13052. Epub 2020 May 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验